Related Experiment Videos
IGF-1, oxidative stress and atheroprotection
Yusuke Higashi1, Sergiy Sukhanov, Asif Anwar
1Tulane University School of Medicine, 1430 Tulane Avenue, SL 48, New Orleans, LA 70112, USA.
Trends in Endocrinology and Metabolism: TEM
|January 15, 2010
Summary
Insulin-like growth factor (IGF)-1 demonstrates antioxidant and anti-inflammatory effects, reducing atherosclerotic burden. This review explores IGF-1
Area of Science:
- Cardiovascular Biology
- Inflammation Research
- Endocrinology
Background:
- Atherosclerosis is a chronic inflammatory disease characterized by endothelial dysfunction and lipoprotein deposition.
- Oxidative stress is a key factor in the initiation, progression, and destabilization of atherosclerotic lesions.
- While many growth factors promote neointima formation, insulin-like growth factor (IGF)-1 exhibits distinct atheroprotective properties.
Purpose of the Study:
- To review the effects of IGF-1 in vascular injury and atherosclerosis models.
- To highlight the relationship between oxidative stress and the atheroprotective actions of IGF-1.
Main Methods:
- Literature review of studies investigating IGF-1 in vascular injury and atherosclerosis.
- Analysis of experimental data from animal models.
Main Results:
- IGF-1 exhibits pleiotropic antioxidant effects.
- IGF-1 demonstrates anti-inflammatory effects.
- These combined effects contribute to a reduced atherosclerotic burden.
Conclusions:
- IGF-1 possesses significant atheroprotective potential.
- Targeting IGF-1 pathways may offer therapeutic strategies for atherosclerosis.
- Understanding the interplay between oxidative stress and IGF-1 is crucial for developing novel treatments.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...